These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 20840545)
1. Is radical prostatectomy a viable therapeutic option in clinically locally advanced (cT3) prostate cancer? Xylinas E; Daché A; Rouprêt M BJU Int; 2010 Dec; 106(11):1596-600. PubMed ID: 20840545 [TBL] [Abstract][Full Text] [Related]
2. [Oncologic and functional outcomes after radical prostatectomy in T3 prostate cancer]. Xylinas E; Misraï V; Comperat E; Renard-Penna R; Vaessen C; Bitker MO; Chartier-Kastler E; Richard F; Cussenot O; Rouprêt M Prog Urol; 2009 May; 19(5):285-90. PubMed ID: 19393531 [TBL] [Abstract][Full Text] [Related]
3. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome. Ward JF; Slezak JM; Blute ML; Bergstralh EJ; Zincke H BJU Int; 2005 Apr; 95(6):751-6. PubMed ID: 15794776 [TBL] [Abstract][Full Text] [Related]
4. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores. Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457 [TBL] [Abstract][Full Text] [Related]
5. Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer. Kupelian P; Katcher J; Levin H; Zippe C; Klein E Urology; 1996 Aug; 48(2):249-60. PubMed ID: 8753737 [TBL] [Abstract][Full Text] [Related]
6. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features. Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249 [TBL] [Abstract][Full Text] [Related]
7. Incidence, etiology, location, prevention and treatment of positive surgical margins after radical prostatectomy for prostate cancer. Wieder JA; Soloway MS J Urol; 1998 Aug; 160(2):299-315. PubMed ID: 9679867 [TBL] [Abstract][Full Text] [Related]
8. [The treatment of locally advanced (T3) prostatic carcinoma using radical prostatectomy or radiotherapy. A review]. van den Ouden D; Schröder FH Tijdschr Gerontol Geriatr; 1998 Apr; 29(2):74-9. PubMed ID: 9615377 [TBL] [Abstract][Full Text] [Related]
9. Intermediate-term potency, continence, and survival outcomes of radical prostatectomy for clinically high-risk or locally advanced prostate cancer. Loeb S; Smith ND; Roehl KA; Catalona WJ Urology; 2007 Jun; 69(6):1170-5. PubMed ID: 17572209 [TBL] [Abstract][Full Text] [Related]
10. [Recurrence following radical surgery for prostatic cancer. Analysis of clinical, biological and anatomo-pathological prognostic factors]. Feyaerts A; Delrée A; Lorge F; Opsomer RJ; Wese FX; Van Cangh PJ; Draguet AP; Cosyns JP Acta Urol Belg; 1997 Mar; 65(1):11-8. PubMed ID: 9245198 [TBL] [Abstract][Full Text] [Related]
11. Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10. Bastian PJ; Gonzalgo ML; Aronson WJ; Terris MK; Kane CJ; Amling CL; Presti JC; Mangold LA; Humphreys E; Epstein JI; Partin AW; Freedland SJ Cancer; 2006 Sep; 107(6):1265-72. PubMed ID: 16900523 [TBL] [Abstract][Full Text] [Related]
12. Radical retropubic prostatectomy in men younger than 45 years diagnosed during early prostate cancer detection program. Varkarakis J; Pinggera GM; Sebe P; Berger A; Bartsch G; Horninger W Urology; 2004 Feb; 63(2):337-41. PubMed ID: 14972485 [TBL] [Abstract][Full Text] [Related]
13. [Radical prostatectomy as monotherapy for locally advanced prostate cancer (T3a): 12 years follow-up]. Isorna Martínez de la Riva S; Belón López-Tomasety J; Marrero Domínguez R; Alvarez Cruz E; Santamaría Blanco P Arch Esp Urol; 2004 Sep; 57(7):679-92. PubMed ID: 15536949 [TBL] [Abstract][Full Text] [Related]
14. Role of early adjuvant hormonal therapy after radical prostatectomy for prostate cancer. Zincke H; Lau W; Bergstralh E; Blute ML J Urol; 2001 Dec; 166(6):2208-15. PubMed ID: 11696737 [TBL] [Abstract][Full Text] [Related]
15. [The role of radical prostatectomy in cT3 prostate carcinoma]. Van Poppel H; Goethuys H; Callewaert P; Vanuytsel L; Van de Voorde W; Baert L Praxis (Bern 1994); 2001 Sep; 90(38):1623-31. PubMed ID: 11675915 [TBL] [Abstract][Full Text] [Related]
16. Identification of factors predicting response to adjuvant radiation therapy in patients with positive margins after radical prostatectomy. Kamat AM; Babaian K; Cheung MR; Naya Y; Huang SH; Kuban D; Babaian RJ J Urol; 2003 Nov; 170(5):1860-3. PubMed ID: 14532793 [TBL] [Abstract][Full Text] [Related]
17. Pathological findings and prostate-specific antigen outcomes after laparoscopic radical prostatectomy for high-risk prostate cancer. Ploussard G; Salomon L; Allory Y; Terry S; Vordos D; Hoznek A; Abbou CC; Vacherot F; de la Taille A BJU Int; 2010 Jul; 106(1):86-90. PubMed ID: 19930177 [TBL] [Abstract][Full Text] [Related]
18. Importance of margin extent as a predictor of outcome after adjuvant radiotherapy for Gleason score 7 pT3N0 prostate cancer. Valicenti RK; Chervoneva I; Gomella LG Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1093-7. PubMed ID: 15001249 [TBL] [Abstract][Full Text] [Related]
19. Long-term data on the survival of patients with prostate cancer treated with radical prostatectomy in the prostate-specific antigen era. Isbarn H; Wanner M; Salomon G; Steuber T; Schlomm T; Köllermann J; Sauter G; Haese A; Heinzer H; Huland H; Graefen M BJU Int; 2010 Jul; 106(1):37-43. PubMed ID: 20002667 [TBL] [Abstract][Full Text] [Related]
20. Clinical utility of percent-positive prostate biopsies in predicting biochemical outcome after radical prostatectomy or external-beam radiation therapy for patients with clinically localized prostate cancer. D'Amico AV; Whittington R; Malkowicz SB; Schultz D; Silver B; Henry L; Hurwitz M; Kaplan I; Beard CJ; Tomaszewski JE; Renshaw AA; Wein A; Richie JP Mol Urol; 2000; 4(3):171-5;discussion 177. PubMed ID: 11062371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]